Cordica Medical, a medical device contract development and manufacturing organization (CDMO), announced that it has acquired RapidWerks’ micro-molding capabilities. The acquisition adds dedicated, fully automated micro-molding for mass production to Cordica’s integrated design and manufacturing platform, including equipment designed for repeatable shot-size accuracy and for producing parts that consistently weigh as little as a fraction of a gram.
This acquisition positions Cordica to produce highly precise micro-molded components across a wide range of medical device applications for customers pursuing miniaturization and functional device integration. Integrated with Cordica’s interventional and critical care capabilities, micro-molding extends the company’s ability to deliver complete, application-ready devices. The acquired capabilities also provide significant capacity to scale with current demand and support future growth.
The acquisition strengthens Cordica’s end-to-end platform, extending its molding capabilities into the sub-gram, micron-tolerance range and adding processing capabilities for demanding materials such as PEEK and bioresorbable polymers. Backed by validated, ISO 13485-certified processes and in-line vision inspection, micro-molding gives device makers a single partner from concept through commercial scale, with the precision, regulatory rigor and supply assurance that next-generation devices demand.
